KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer

Kristen S. Hill(University of Kentucky), Jill Kolesar(University of Kentucky), Erin E. Schuler(University of Kentucky), Sally R. Ellingson(University of Kentucky), Anthony McDowell(University of Kentucky), J. Robert McCorkle(St. Jude Children's Research Hospital), Rina Plattner(University of Kentucky)

Cancers

April 14, 2021

10.3390/cancers13081885

Cited by 23

Related Papers

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF

|Genes & Development|1999|426

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

|JAMA|2015|285

Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells

|Cancer Research|2006|199

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

|Nature Genetics|2015|162

Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1

|PLoS ONE|2013|133